Carbapenem Resistance in Enterobacteria

1. Amaral, L. Response of regulatory, efflux pump transporter and Omp genes during prolonged antibiotic stress and development of MDR in Gram-negative bacteria, Clin Microbiol Infect, 2008, Suppl. ECCMID 2008 Abstracts, S388.

2. Ambler, R.P. The structure of β-lactamases. Phil Trans R Soc Lond Biol, 1980, 289, 321-331.

3. Anderson, K.F., Lonsway, D.R., Rasheed, J.K., Biddle, J. et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microb, 2007, 45, 2723-2725.

4. Arakawa, Y, Shibata, N, Shibayama, K, Kurokawa, H. et al. Convenient test for screening metallo-β-lactamase-producing Gram-negative bacteria by using thiol compounds. J Clin Microb, 2000, 38, 40-43.

5. Baudry, P.J., Nichol, K., DeCorby, M., Mataseje, L. et al. Comparison of antimicrobial resistance profiles among extended-spectrum-beta-lactamase-producing and acquired AmpC beta-lactamase-producing Escherichia coli isolates from Canadian intensive care units. Antimicrob Agents Chemother, 2008, 52, 1846-1849.

6. Bauernfeind, A., Grimm, H., Schweighart, S. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection, 1990, 18, 294-298.

7. Bauvois, C., Ibuka, A.S., Celso, A., Alba, J. et al. Kinetic properties of four plasmid-mediated AmpCβ--lactamases, Antimicrob Agents Chemother, 2005, 49, 4240-4246.

8. Bebrone, C. Metallo-β-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. Biochem Pharmacol, 2007, 74, 1686-1701.

9. Bergerová, T, Hedlová, D, Jindrák, V, Urbášková, P. et al. Doporučený postup pro kontrolu výskytu kmenů Staphylococcus aureus rezistentních k oxacilinu (MRSA) a s jinou nebezpečnou antibiotickou rezistencí ve zdravotnických zařízeních. Prakt Lék, 2006, 86, 500–506. Dostupný také na WWW (http://www. cls.cz/dokumenty/dp_mrsa.doc).

10. Bidet, P., Burghoffer, B., Gautier, V., Brahimi, N. et al. In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability in K. pneumoniae. Antimicrob Agents Chemother, 2005, 49, 3562-3565.

11. Bradford, P. Extended-spectrum-β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev, 2001, 14, 933-951.

12. Bradford, P., Urban, C., Mariano, N., Projan, S. et al. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and loss of an outer memebrane protein. Antimicrob Agents Chemother, 1996, 41, 563-569.

13. Bush, K., Jacoby, G.A., Medeiros, A.A. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother, 1995, 39, 1211-1233.

14. Bush, K., Singer, S.B. Biochemical characteristics of extended broad spectrum β-lactamases. Infection, 1989, 17, 429-433.

15. Castanheira, M., Mendes, R.E., Walsh, T.R., Gales, A.C. et al. Emergence of the extended-spectrum beta-lactamase GES-1 in a Pseudomonas aeruginosa strain from Brazil: report from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother, 2004, 48, 2344-2345.

16. Castanheira, M., Toleman, M.A., Jones, R.N., Schmidt, F.J. et al. Molecular characterization of a β-lactamase gene, blaGIM-1, encoding a new subclass of metallo-β-lactamase. Antimicrob Agents Chemother, 2004, 48, 4654-β-4661.

17. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: sixteenth informational supplement. CLSI Document M100-S-16, PA, USA, 2006.

18. Cornaglia, G., Akova, M., Amicosante, G., Cantón, R. et al. Metallo-β-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. Int J Antimicrob Agents, 2007, 29, 380-388.

19. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum ß-lactamase CTX-M-15. Emerg Infect Dis, 2008, 14, 195-200.

20. Crowley, B., Benedí, J.V., Doménech-Sanchez, A. Expression of SHV-2 beta–lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems. Antimicrob Agents Chemother, 2002, 46, 3679-3682.

21. Daikos, G.L., Kosmidis, C., Tassios, P.T., Petrikkos, G. et al. Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome. Antimicrob Agents Chemother, 2007, 2366‑2372.

22. Doménech-Sanchez, A., Martínez-Martínez, L., Hernendéz-Allés, S., Carmen Conejo, M. et al. Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance. Antimicrob Agents Chemother, 2003, 47, 3332-3335.

23. Duarte, A., Boavida, F., Grosso, F., Correia, M. et al. Outbreak of GES-1 beta-lactamase-producing multidrug-resistant Klebsiella pneumoniae in a university hospital in Lisbon, Portugal. Antimicrob Agents Chemother, 2003, 47, 1481-1482.

24. Endiamini, A., Carias, L.L., Hujer, A.M., Bethel, C.R. et al. Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States. Antimicrob Agents Chemother, 2008, 52, 2680-2682.

25. Endiamini, A., Hujer, K.M., Carias, L.L., Perez, F. et al. Emergence of plasmid-mediated quinolone resistance in blaKPC – containing Klebsiella pneumoniae in the United States. 10th Beta-Lactamase Meeting Abstracts, Eretria, Řecko, 2008, 12.

26. Espedido, B.A., Thomas, L.C., Iredell, J.R. Metallo--β-lactamase or extended-spectrum β-lactamase: a wolf in sheep’s clothing. J Clin Microb, 2007, 45, 2034-2036.

27. Ferro-Luzzi, A.G. Resolution of bacterial proteins by polyacrylamide gel electrophoresis on slabs, membrane, soluble, and periplasmic fractions. J Biol Chem, 1973, 249, 634-644.

28. Fiett, J, Baraniak, A, Mrówka, A, Fleischer, M. et al. Molecular epidemiology of acquired-metallo-β--lactamase-producing bacteria in Poland. Antimicrob Agents Chemother, 2006, 50, 880-886.

29. Franklin, C, Liolios, L, Peleg, AY. Phenotypic detection of carbapenem-susceptible metallo-β--lactamase-producing Gram-negative bacilli in the clinical laboratory. J Clin Microb 2006; 44: 3139-3144.

30. Fritsche, T.R., Sader, H.S., Toleman, M.A., Walsh, T.R. et al. Emerging metallo-beta-lactamase-mediated resistance: a summary report from the worldwide SENTRY antimicrobial surveillance program. Clin Infect Dis, 2005, 41(Suppl. 4), 276-278.

31. Galani, I., Souli, M., Koratzanis, E., Chryssouli, Z. Molecular characterization of an Escherichia coli clinical isolate that produces both metallo-β-lactamase VIM-2 and extended-spectrum β-lactamase GES-7: identification of the In8 integron carrying the blaVIM-2 gene. J Antimicrob Chemother, 2006, 58, 432-433.

32. Galani, I., Souli, M., Chryssouli, Z., Katsala, D. et al. First identification of an Escherichia coli clinical isolate producing both metallo-β-lactamase VIM-2 and extended-spectrum β-lactamase IBC-1. Clin Microb Infect, 2004, 10, 749-772.

33. Galani, I., Souli, M., Chryssouli, Z., Orlandou, K. et al. Characterization of a new integron containing blaVIM-1 and aac(6’)-IIc in an Enterobacter cloacae clinical isolate from Greece. J Antimicrob Chemother, 2005, 55, 634-638.

34. Galani, I., Souli, M., Koratzanis, E., Koratzanis, G. et al. Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-β-lactamase VIM-1 in Greece. J Antimicrob Chemother, 2007, 59, 578-579.

35. Garau, G., Di Guilmi, A.M., Hall, B.G. Structure-based phylogeny of the metallo-β-lactamases. Antimicrob Agents Chemother, 2005, 49, 2778-2784.

36. Giakkoupi, P., Vourli, S., Polemis, M., Vatopoulos A. Emergence of KPC-producing Klebsiella pneumoniae in Greece. 10th Beta-Lactamase Meeting Abstracts, Eretria, Řecko, 2008, 14.

37. Giakkoupi, P., Xanthaki, A., Kanelopoulou, M., Vlahaki, A. et al. VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae strain in Greek hospitals. J Clin Microb, 2003, 41, 3893-3896.

38. Gibb, A.P., Tribuddharat, C., Moore, R.A., Louie, T.J. et al. Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new blaIMP allele, blaIMP-7. Antimicrob Agents Chemother, 2002, 46, 255-258.

39. Gniadkowski, M. Evolution and epidemiology of extended-spectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms. Clin Microb Infect, 2001, 7, 597-608.

40. Grespo, M.P., Woodford, N., Sinclair, A., Kaufmann, M.E. et al. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia J Clin Microb, 2004, 42, 5094-5101.

41. Guillier, M., Gottesman, S., Storz, G. Modulating the outer membrane with small RNAs, Genes Dev., 2006, 20, 2338-2348.

42. Hawkey, P., Finch, R. Tigecycline: in-vitro performance as a predictor of clinical efficacy. Clin Microbiol Infect, 2007, 13, 354-362.

43. Hensyl, W.R. Bergey’s manual of determinantive bacteriology., Williams and Wilkins, Baltimore, USA, 1994.

44. Hernandéz-Allés, S., Carmen-Conejo, M., Pascual, A., Tomás, J.M. et al. Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae, Journal of Antimicrobial Chemotherapy, 2000, 46, 273-277.

45. Herbert, S., Halvorsen, D.S., Franklin, C., Spelman, D. Large outbreak of infection and colonization with Gram-negative pathogens carrying the metallo-β-lactamase gene blaIMP-4 at a 320-Bed tertiary hospital in Australia. Infect Control Hosp Infect, 2007, 28, 98-101.

46. Hrabák, J. Klinicky významné β-laktamázy gramnegativních bakterií: širokospektré β-laktamázy (ESBL). Epid mikrob imunol, 2007, 56, 103-111.

47. Hrabák, J. Klinicky významné β-laktamázy gramnegativních bakterií: AmpC. Epid mikrob imunol 2007, 56, 155-165.

48. Hrabák, J., Vaniš, V., Bergerová, T., Urbášková, P. Průkaz β-laktamáz širokého spektra (ESBL) a typu AmpC u enterobakterií. Zprávy CEM, 2007, 16, 31-36.

49. Hrabák, J., Vaniš, V., Bergerová, T., Jindrák, V. et al. Průkaz metalo-β-laktamáz (MBL) u gramnegativních bakterií. Zprávy CEM, 2007, 16, 417-422.

50. Jacoby, G.A. ß-lactamase nomenclature. Antimicrob Agents Chemother, 2006, 50, 1123-1129.

51. Jones, R.N., Biedenbach, D.J., Sader, H.S., Fritsche, T.R. et al. Emerging epidemic of metallo-beta-lactamase-mediated resistance. Diagn Microbiol Infect Dis, 2005, 51, 77-84.

52. Kaczmarek, F.M., Dib-Hajj, F., Shang, W., Gootz, T.D. High-level carbapenem resistance in Klebsiella pneumoniae clinical isolate is due to the combination of bla ACT-1 beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE. Antimicrob Agents Chemother, 2006, 50, 3396-3406.

53. Kang, C.I., Kim, S.H., Park, W.B., Lee K.D. et al. Bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother, 2004, 48, 4574-4581.

54. Karabinis, A., Paramythiotou, E., Mylona-Petropoulou, D., Kalogeromitros, A. et al. Colistin for Klebsiella pneumoniae-associated sepsis. Clin Infect Dis, 2004, 38, 7-9.

55. Ktari, S., Arlet, G., Mnif, B., Gautier, V. et al. Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-β--lactamase, CTX-M-15 extended-spectrum β-lactamase, and CMY-4 AmpC β-lactamase in a Tunisian university hospital. Antimicrob Agents Chemother, 2006, 4198‑4201.

56. Lartigue, M.F., Poirel, L., Aubert, D., Nordmann, P. In vitro analysis of ISEcp1B-mediated mobilization of naturally occuring beta-lactamase gene blaCTX-M of Kluyvera ascorbata, Antimicrob Agents Chemother, 2006, 50, 1282-1286.

57. Lauretti, L., Riccio, M.L., Mazzariol, A., Cornaglia, G. et al. Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother, 1999, 43, 1584-1590.

58. Leavitt, A., Navon-Venezia, S., Chmelnitsky, I., Schwaber, M.J. et al. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother, 2007, 51, 3026 - 3029.

59. Leclercq, R., Cantón, R., Giske, C., Heisig, P. et al. Expert rules in antimicrobial susceptibility testing. European Committee on Antimicrobial Susceptibility Testing, 2008, http://www.srga.org/eucastwt/EUCAST %20Expert%20rules%20final%20April_20080407.pdf.

60. Lee, K., Yong, D., Choi, Y.S., Yum, J.H. et al. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss. Int J Antimicrob Agents, 2006, 29, 201-206.

61. Lee, K., Yum, J.H., Yong, D., Lee, H.M. et al. Novel acquired metallo-β-lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea, Antimicrob Agents Chemother, 2005, 49, 4485-4491.

62. Livermore, D.M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis, 2002, 34, 634-640.

63. Livermore D.M., Woodford N. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter, Trends Microbiol., 2006, 14, 413-420.

64. Martínez-Martínez, L., Pascual, A., Hernendéz-Allés, S., Alvarez-Díaz, D. et al. Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob Agents Chemother, 1999, 43, 1669-1673.

65. Martínéz-Martínéz, L. Extended-spectrum beta-lactamases and the permeability barrier., Clin Microbiol Infect, 2008, 14(suppl.1), 82-89.

66. Massidda, O., Rossolini, G.M., Satta, G. The Aeromonas hydrophila cphA gene: molecular heterogenity among class B metallo-ß-lactamases. J Bacteriol, 1991, 173, 4611-4617.

67. Matthaiou, D.K., Michalopoulos, A., Rafailidis, P.I., Kirageorgopoulos, D.E. et al. Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit Care Med, 2008, 36, 807 - 811. Crit. Care Med.

68. Mazura, N., Sakagawa, E., Ohya, S. Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother, 1995, 39, 645-649.

69. Mena, A., Plasencia, V., García, L., Hidalgo, O. et al. Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leasing to in vivo carbapenem resistance development. J Clin Microb, 2006, 44, 2831- 2837.

70. Migliavacca, R., Docquier, J.-D., Mugnaioli, C., Amicosante, G. et al. Simple microdilution test for detection of metallo-β-lactamase production in Pseudomonas aeruginosa. J Clin Microb, 2002, 40, 4388‑4390.

71. Miriagou, V., Tzelepi, E., Daikos, G.L., Tassios, P.T. et al. Panresistance in VIM-1-producing Klebsiella pneumoniae. J Antimicrob Chemother, 2005, 55, 810‑811.

72. Miriagou, V., Tzelepi, E., Giannele, D., Tzouvelekis, L.S. Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo--β-lactamase VIM-1. Antimicrob Agents Chemother, 2003, 47, 395-397.

73. Moland, E.S., Hong, S.G., Thomson, K.S., Larone, D.H. et al. Klebsiella pneumoniae isolate producing at least eight different beta-lactamases, including AmpC and KPC beta-lactamases. Antimicrob Agents Chemother, 2007, 51, 800-801.

74. Naas, T., Cuzon, G., Villegas, M.V., Lartigue, M.F. et al. Genetic structures at the origin of aquisition of the beta-lactamase blaKPC gene. Antimicrob Agents Chemother, 2008, 52, 1257-1263.

75. Nicodemo, A.C., Garcia Paez, J.I. Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis, 2007, 26, 229-237.

76. Nikaido, H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev, 2003, 67, 593-656.

77. Nikaido, H. Transport across the bacterial outer membrane., J Bioenerg Biomembr, 1993, 25, 581-9.

78. Nikaido, H. Proteins forming large channels from bacterial and mitochondrial outer membranes: porins and phage lambda receptor proteins. Methods Enyzmol 1983, 97, 85-100.

79. Nordmann, P. AmpCs, carbapenemases and carbapenem resistance, Clin Microbiol Infect, 2008, Suppl. ECCMID 2008 Abstracts, S127.

80. Osano, E., Arakawa, Y., Wacharotayankum, R., Ohta, M. et al. Molecular characterization of an enterobacterial metallo-beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother, 1994, 38, 71-78.

81. Panagiotakopoulou, A., Daikos, G.L., Miriagou, V., Loli, A. et al. Comparative in vitro killing of carbapenems and aztreonam against Klebsiella pneumoniae producing VIM-1 metallo-β-lactamase. Int J Antimicrob Agents, 2007, 29, 356-365.

82. Poeylaut, A.A., Tomatis, P.E., Karsisiotis, A.I., Damblon, C. et al. A minimalistic approach to identify substrate binding features in B1 metallo-β-lactamases. Bioorg Med Chem Lett, 2007, 17, 5171-5174.

83. Poirel, L., Cabanne, L., Collet, L., Nordmann, P. Clas II transposon-borne structure harboring metallo-β-lactamase gene blaVIM-2 in Pseudomonas putida. Antimicrob. Agents Chemother, 2006, 50, 2889‑2891.

84. Poirel, L., Decousser, J.W., Nordmann, P. Insertion sequence ISEcp1B is involved in expression and mobilization of blaCTX-M beta-lactamase gene. Antimicrob Agents Chemother, 2003, 47, 2938-2945.

85. Poirel, L., Hériter, C., Tolün, V., Nordmann, P. Emergence of oxacilinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother, 2004, 48, 15-22.

86. Poirel, L., Lartigue, M.F., Decousser, J.W., Nordmann, P. ISEcp1B-mediated transposition of blaCTX-M in Escherichia coli. Antimicrob Agents Chemother, 2004, 49, 447-550.

87. Poirel, L., Weldhagen, G.F., Naas, T., Champs, C.D. et al. GES-2, a class A β-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob Agents Chemother, 2001, 45, 2598-2603.

88. Pournaras, S., Ikonomidis, A., Tzouvelekis, L.S., Tokatlidou, D. VIM-12, a novel plasmid-mediated metallo-β-lactamase from Klebsiella pneumoniae that resembles a VIM-1/VIM-2 hybrid. Antimicrob Agents Chemother, 2005, 49, 5153-5156.

89. Pournaras, S., Maniati, M., Spanakis, N., Ikonomidis, A., et al. Spread of efflux pump-overexpressing, non-metallo-β-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity. J Antimicrob Chemother, 2005, 56, 761-764.

90. Queenan, A.M., Bush, K. Carbapenemase: the versatile β-lactamases. Clin Microb Rev, 2007, 20, 440‑458.

91. Rasheed, J.K., Biddle, J.W., Anderson, K.F., Washer, L. et al. Detection of the Klebsiella pneumoniae carbapenemase type 2 Carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid. J Clin Microbiol, 2008, 46, 2066-2069.

92. Rodríguez-Martínez, J.-M., Pascual, A., García, I., Martínez-Martínez, L. Detection of plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type β-lactamase. J Antimicrob Chemother, 2003, 52, 703‑706.

93. Rodríguez-Martínez, J.M., Pichardo, C., García, I., Pachón-Ibanez, M.E. et al. Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and producing QnrA1. Clin Microb Infect, 2008, 14, 691-697.

94. Rossoliny, G.M. Acquired metallo-β-lactamases: an increasing clinical threat. Clin Infect Dis, 2005, 41, 1557-1558.

95. Rossoliny, G.M., Mantengoli, E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa Clin Microb Infect, 2005, 11(Suppl. 4), 17-32.

96. Samra, Z., Ofir, O., Lishtzinsky, Y., Madar-Shapiro, L. et al. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int J Antimicrob Agents, 2007, 30, 525-529.

97. Simona, F., Magistrato, A., Vera, D.M.A., Garau, G. et al. Protonation state and substrate binding to B2 metallo-β-lactamase CphA from Aeromonas hydrofila. Proteins, 2007, 69, 595-605.

98. Siu, L.K. Antibiotics: action and resistance in gram-negative bacteria. J Microbiol Immunol Infect, 2002, 35, 1-11.

99. Smith Moland, E., Hanson, N.D., Herrera, V.L., Black, J.A. et al. Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J Antimicrob Chemother, 2003, 51, 711-714.

100. Stapleton, P.D., Shannon, K.P., French, G.L. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 ß-lactamase production and loss of an outer membrane protein. Antimicrob Agents Chemother, 1999, 43, 1206-1210.

101. Samuelsen, O. Emergence of KPC and MBLs in Scandinavia. 10th Beta-Lactamase Meeting Abstracts, Eretria, Řecko, 2008, 15.

102. Sharma, N., Toney, J.H., Fitzgerald, P.M.D. Expression, purification, crystalization and preliminary X-ray analysis of Aeromonas hydrophilia metallo-β-lactamase. Acta Cryst, 2005, F61, 180-182.

103. Stoczko, M., Frére, J.-M., Rossoliny, G.M., Docquier, J.-D. Postgenomic scan of metallo-β-lactamase homologues in Rhizobacteria: identification and characterization of BJP-1, a subclass B3 ortholog from Bradyrhizobium japonicum. Antimicrob Agents Chemother, 2006, 50, 1973-1981.

104. Tascini, C., Urbani, L., Biancofiore, G., Rossoliny, G.M. et al. Colistin in combination with rifampin and imipenem for treating a blaVIM-1 metallo-β-lactamase producing Enterobacter cloacae disseminated infection in a liver transplant patient. Minerva Anestesiol, 2008, 74, 47-49.

105. Toleman, M.A., Simm, A.M., Murphy, T.A., Gales, A.C. et al. Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. J Antimicrob Chemother, 2002, 50, 673‑679.

106. Urbášková, P. Rezistence bakterií k antibiotikům. Vybrané metody. Praha: Trios, 1998.

107. Urbášková, P., Jakubů, V., Žemličková, H., Macková, B. a CZ-EARSS. Rezistence k antibiotikům u sedmi druhů invazivních bakterií, sledovaných v rámci EARSS v České republice v letech 2000-2006. Prakt Lék, 2007, 87, 32-39.

108. Vakulenko, S. GES β-lactamases: Evolution of resistance. 10th Beta-Lactamase Meeting Abstracts, Eretria, Řecko, 2008, 28.

109. Villegas, M.V., Lolans, K., Correa, A. Kattan, J.N. et al. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother, 2007, 51, 1553-1555.

110. Vourli, S., Tsorlini, H., Katsifa, H., Polemis, M. et al. Emergence of Proteus mirabilis carrying the blaVIM-1 metallo-β-lactamase gene. Clin Microb Infect, 2006, 12, 672-694.

111. Wachino, J., Doi, Y., Yamane, K., Shibata, N. et al. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan, Antimicrob Agents Chemother, 2004, 48, 1960‑1967.

112. Walsh, T.R., Toleman, M.A., Poirel, L., Nordmann, P. Metalo-ß-lactamases: the quiet before the storm? Clin Microb Rev, 2005, 18, 306-325.

113. Wang, A., Yang, Y., Lu, Q., Wang, Y. et al. Presence of qnr gene in Escherichia coli and Klebsiella pneumoniae resistant to ciprofloxacin isolated from pediatric patients in China. BMC Infect Dis, 2008, 22, 8:68.

114. Woodford, N., Zhang, J.C., Warner, M., Kaufmann, M.E. et al. Arrival of KPC carbapenemase-producing Klebsiella pneumoniae in the United Kingdom: an Israel connection. 10th Beta-Lactamase Meeting Abstracts, Eretria, Řecko, 2008, 13.

115. Wu, J.-J., Ko, W.-C., Tsai, S.-H., Yan, J.-J. Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese Hospital. Antimicrob Agents Chemother, 2007, 51, 1223-1227.

116. Xu, D., Xie, D., Guo, H. Catalytic mechanism of class B2 metallo-β-lactamase. J Biol Chem 2006, 281, 8740-8747.

117. Yan, J.-J., Ko, W.-C., Tsai, S.-H., Wu, H.-M. et al. Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying blaIMP-8 in a university medical center in Taiwan. J Clin Microbiol, 2001, 39, 4433-4439.

118. Zavascki, A. P., Barth, A. L., Fernandes, J. F., Moro, A. L. D. et al. Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-β-lactamase-mediated multidrug resistance: a prospective observational study. Crit Care, 2006, 10, R114.

119. Zavascki, A.P., Barth, A.L., Goncalves, A.L., Moro, A.L. et al. The influence of metallo-β-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections. J Antimicrob Chemother, 2006, 58, 387-392.

120. Zavascki, A.P., Gaspareto, P.B., Martins, A.F., Goncalves, A.L. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-β-lactamase in a teaching hospital in southern Brazil. J Antimicrob Chemother, 2005, 56, 1148-1151.